CALIFORNIA LIFE SCIENCES

Educate policymakers and regulators on the unique role of mergers and acquisitions in the life sciences industry

Oppose "march-in" rights and "compulsory licensing" proposals Support protection of the Bayh-Dole Act and tech transfer process Oppose policy proposal requiring Access Plans to be part of licensing agreements for NIH owned inventions Support transferable exclusivity extensions to incentivize novel antibiotic and rare disease R&D

Oppose legislative proposal to reform Patent system and Intellectual Property issues impacting the life sciences ecosystem Support capping Medicare beneficiary out of pocket costs Support legislation to expand and clarify the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program Oppose CMS proposed changes to the Medicaid Drug Rebate Program (MDRP) to redefine how Medicaid Best Price is calculated Support improvements to manufacturer and stakeholder input processes within the Medicare Drug Price Negotiation Program Support legislation providing Medicare coverage for anti-obesity medication Support improvements to manufacturer engagement process for Small Biotech Exemption within MDPNP CMS CY2025 Hospital Outpatient Prospective Payment System (OPPS) proposed rule

Support R&D and NOL tax incentives, Orphan Drug Tax Credits Support legislation to restore the immediate expensing of research and development

Support diversity in clinical trial policy Oppose legislation that expands Medicare Drug Pricing Negotiation Program (MDPNP) Support bipartisan effort to address health care workforce shortage Support incentives for antimicrobial resistance development (PASTEUR Act) Support legislation that applies additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans Support legislation to prohibit pharmacy benefit managers (PBMs) from linking rebates paid by manufacturers to the list price of a drug and instead implement a flat service fee paid to PBMs Educate Congress on the current state of artificial intelligence in health care and the current regulatory landscape Support legislation to modernize the U.S. Preventive Services Task Force (USPSTF) Support electronic labeling for all medical devices, regardless of setting of use or the intended user (Medical Device Electronic Labeling Act)